Home » Stocks » EUCR

Eucrates Biomedical Acquisition Corp. (EUCR)

Stock Price: $10.36 USD -0.14 (-1.33%)
Updated Jan 25, 2021 4:00 PM EST - Market closed
Market Cap 141.99M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 12.85M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 25
Last Price $10.36
Previous Close $10.50
Change ($) -0.14
Change (%) -1.33%
Day's Open 10.63
Day's Range 10.35 - 10.59
Day's Volume 66,239
52-Week Range 10.00 - 10.59

News

Hide News
PRNewsWire - 2 months ago

NEW YORK, Oct. 27, 2020 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchang...

PRNewsWire - 3 months ago

NEW YORK, Oct. 23, 2020 /PRNewswire/ -- Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchang...

About EUCR

Eucrates Biomedical Acquisition is a newly organized blank check company incorporated on August 21, 2020 as a British Virgin Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and capitalize on the ability of ou... [Read more...]

Industry
Shell Companies
IPO Date
Oct 23, 2020
CEO
Parag Phoolchand Saxena MBA, MS
Country
United States
Stock Exchange
NASDAQ
Ticker Symbol
EUCR
Full Company Profile